iph6501
Generic: Zemlikafusp Alfa
iph6501: 1 clinical trial tracked.
iph6501 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about iph6501, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
A Phase 1/2, Open-Label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Antineoplastic Activity of IPH6501 in Patients With Relapsed and/or Refractory CD20-expressing Non-Hodgkin Lymphoma
Primary endpoint: Safety and tolerability
Interventionalopen23 targetStarted 2024-03Completion 2026-0214 sites · Australia, France, United StatesInnate Pharma